Arcturus therapeutics Contact Number

All Time Past 24 Hours Past Week Past month Post Your Comments?

Listing Results Arcturus therapeutics Contact Number

Contact Information Arcturus Therapeutics

1 hours ago Arcturusrx.com Show details

(858) 900-2660Contact Us Headquarters. Arcturus Therapeutics, Inc. 10628 Science Center Drive, Suite 250 San Diego, CA 92121 [email protected] (858) 900-2660 Directions

1. 10628 Science Center Dr Ste 250, San Diego, CA 92121

Category: Contact SupportShow more

Arcturus Therapeutics Crunchbase Company Profile & …

1 hours ago Crunchbase.com Show details

858-900-2660Contact Email [email protected] Phone Number 858-900-2660. Arcturus Therapeutics focuses on developing novel RNA therapeutics for the treatment of various diseases aiming at Rare Diseases. The company owns Unlocked Nucleic Acid (UNA) chemistry technology and patent portfolio (32 patents, USPTO granted) enabling the targeting of any gene in

Founded: 2013
Founders: Joseph E Payne, Padmanabh Chivukula

Category: Contact NumberShow more

Arcturus Therapeutics Building Next Generation RNA …

3 hours ago Arcturusrx.com Show details

Arcturus Therapeutics is a leading clinical-stage messenger RNA medicines company focused on the discovery, development and commercialization of therapeutics for rare diseases and vaccines. We have proprietary technologies, validating partnerships, and an experienced team with deep expertise in delivery and RNA-based therapeutics. Corporate Deck.

Category: Contact NumberShow more

Arcturus Therapeutics Holdings Inc. Company Profile San

8 hours ago Dnb.com Show details

(858) 900-2660Company Description: Arcturus Therapeutics Holdings Inc. is located in San Diego, CA, United States and is part of the Pharmaceutical and Medicine Manufacturing Industry. Arcturus Therapeutics Holdings Inc. has 118 total employees across all of its locations and generates $9.54 million in sales (USD).

Employees: 118
Phone: (858) 900-2660
Location: 10628 Science Center Dr Ste 250, San Diego, 92121-1132, CA

Category: Contact NumberShow more

Arcturus Therapeutics Reports Inducement Grant Under

9 hours ago Streetinsider.com Show details

(858) 900-2682Arcturus Therapeutics Deepankar Roy, Ph.D. (858) 900-2682 [email protected] Kendall Investor Relations Carlo Tanzi, Ph.D. (617) 914-0008 [email protected] Source: Arcturus Therapeutics

Category: Contact NumberShow more

Arcturus Therapeutics Employees, Board Members, …

8 hours ago Crunchbase.com Show details

Arcturus Therapeutics has 8 current employee profiles, including Founder, President & CEO Joseph Payne. Arcturus Therapeutics has 5 board members and advisors, including Joseph Payne . Contacts

Category: Contact NumberShow more

Arcturus Therapeutics Reports Inducement Grant Under

2 hours ago Ir.arcturusrx.com Show details

SAN DIEGO--(BUSINESS WIRE)--Nov. 18, 2021-- Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a leading clinical-stage messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases, today announced that the …

Category: Contact NumberShow more

FORM D SEC

4 hours ago Sec.gov Show details

(858) 900-2660Arcturus Therapeutics, Inc. Street Address 1 Street Address 2; 10628 SCIENCE CENTER DRIVE, SUITE 200: City State/Province/Country ZIP/PostalCode Phone Number of Issuer; SAN DIEGO: CALIFORNIA: 92121 (858) 900-2660

Category: Contact NumberShow more

Arcturus Therapeutics Reports New Data and Provides

8 hours ago Pipelinereview.com Show details

SAN DIEGO, CA, USA I December 16, 2021 I Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a leading clinical-stage messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases, today announced new data and

Category: Contact NumberShow more

Arcturus Group, Inc. USDOT 2822451 Dayton, Ohio Trucking

7 hours ago Quicktransportsolutions.com Show details

Arcturus Group, Inc. is a licensed and bonded freight shipping and trucking company running freight hauling business from Dayton, Ohio. Arcturus Group, Inc. USDOT number is 2822451. Arcturus Group, Inc. is trucking company providing freight transportation services and hauling cargo. Insurance carriers from insurance history of Arcturus Group, Inc. are Progressive …

Category: Contact NumberShow more

Arcturus Therapeutics Reports Inducement Grant Under

Just Now Ir.arcturusrx.com Show details

SAN DIEGO--(BUSINESS WIRE)--Oct. 20, 2021-- Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a leading clinical-stage messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases, today announced that the …

Category: Contact NumberShow more

Arcturus Therapeutics Reports Inducement Grant Under

Just Now Businesswire.com Show details

(858) 900-2682Arcturus Therapeutics Deepankar Roy, Ph.D. (858) 900-2682 [email protected] Kendall Investor Relations Carlo Tanzi, Ph.D. (617) 914-0008 [email protected] Site Navigation Home

Category: Contact NumberShow more

Arcturus Therapeutics Reports Inducement Grant Under

6 hours ago Biospace.com Show details

(858) 900-2682Arcturus Therapeutics Deepankar Roy, Ph.D. (858) 900-2682 [email protected] Kendall Investor Relations Carlo Tanzi, Ph.D. (617) 914-0008 [email protected]

Category: Contact NumberShow more

Arcturus Therapeutics Holdings (NASDAQ:ARCT) Has Debt But

8 hours ago Nasdaq.com Show details

You can click the graphic below for the historical numbers, but it shows that as of September 2021 Arcturus Therapeutics Holdings had US$60.8m of debt, an increase on US$15.1m, over one year

Category: Contact NumberShow more

Arcturus Therapeutics BIO International Convention BIO

1 hours ago Bio.org Show details

Founded in 2013 and based in San Diego, California, Arcturus Therapeutics Holdings Inc. (Nasdaq: ARCT) is a clinical-stage mRNA medicines and vaccines company with enabling technologies: (i) LUNAR® lipid-mediated delivery, (ii) STARR™ mRNA Technology and (iii) mRNA drug substance along with drug product manufacturing expertise.

Category: Contact NumberShow more

Stock Alert: Arcturus Therapeutics Stock Up 17% In Pre

5 hours ago Nasdaq.com Show details

020-03-04(RTTNews) - Shares of Arcturus Therapeutics Holdings Inc. (ARCT) are up $2.52 or 17.38% to $17.02 in the pre-market session today, after the company announced a partnership with Duke-NUS Medical

Category: Contact NumberShow more

Arcturus Therapeutics Reports Inducement Grant Under

6 hours ago Benzinga.com Show details

Arcturus Therapeutics Holdings Inc. with 25% of the number of shares underlying the stock option vesting on one-year anniversary of the applicable vesting commencement date (based on the

Category: Contact NumberShow more

Arcturus Therapeutics Reports New Data and Provides

7 hours ago Perutribune.com Show details

Business Wire Dec 16, 2021 Dec 16, 2021 Updated Dec 16, 2021

Category: Contact NumberShow more

Arcturus Therapeutics Holdings Inc. Expected to Earn

9 hours ago Marketbeat.com Show details

Arcturus Therapeutics (NASDAQ:ARCT) last issued its quarterly earnings data on Monday, November 8th. The biotechnology company reported ($2.05) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of ($1.40) by ($0.65). Arcturus Therapeutics had a negative return on equity of 55.78% and a negative net margin of …

Category: Contact NumberShow more

Arcturus Therapeutics, Inc., Jobs & Salary for Foreign

3 hours ago Myvisajobs.com Show details

Arcturus Therapeutics, Inc. has filed 14 labor condition applications for H1B visa and 3 labor certifications for green card from fiscal year 2019 to 2021. Arcturus Therapeutics was ranked 11317 among all visa sponsors. Please note that 1 LCA for H1B Visa and 0 LC for green card have been denied or withdrawn during the same period.

Category: Contact NumberShow more

Arcturus Therapeutics Appoints Jing Marantz, M.D., Ph.D

7 hours ago Roanoke.com Show details

Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a leading clinical-stage messenger RNA medicines company focused on …

Category: Contact NumberShow more

Arcturus—a clinicalstage mRNA therapeutics and vaccines

Just Now Nature.com Show details

747-021-0007Neda Safarzadeh, Sr. Director, Head of IR, PR & Marketing, Arcturus Therapeutics Holdings Inc., San Diego, CA, USA, Tel: +1-858-900-2682 Arcturus Therapeutics, based in San Diego, has proprietary

Category: Contact NumberShow more

Arcturus Therapeutics and Catalent Announce Partnership to

3 hours ago Benzinga.com Show details

Arcturus Therapeutics Holdings Inc. (("Arcturus", "the Company", NASDAQ:ARCT), a leading clinical-stage messenger RNA (mRNA) medicines and vaccines company, and Catalent, Inc. (NYSE:CTLT), the

Category: Contact NumberShow more

Arcturus Therapeutics Wikipedia

1 hours ago En.wikipedia.org Show details

Revenue. $21 Million (2019) Number of employees. 124. Website. www .arcturusrx .com. Arcturus Therapeutics is an American RNA medicines biotechnology company focused on the discovery, development and commercialization of therapeutics for rare diseases and infectious diseases. Arcturus has developed a novel, potent, and safe RNA therapeutics

Category: Contact NumberShow more

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Receives

7 hours ago Marketbeat.com Show details

Arcturus Therapeutics (NASDAQ:ARCT) last announced its quarterly earnings data on Monday, November 8th. The biotechnology company reported ($2.05) earnings per share for the quarter, missing the consensus estimate of ($1.40) by ($0.65). Arcturus Therapeutics had a negative net margin of 2,227.82% and a negative return on equity of 55.78%.

Category: Contact NumberShow more

Arcturus Therapeutics Holdings Number of Employees 2012

7 hours ago Macrotrends.net Show details

Arcturus Therapeutics Holdings number of employees from 2012 to 2021. Number of employees can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis

Category: Contact NumberShow more

Buy Arcturus Therapeutics Holdings Inc stock & View ($ARCT

4 hours ago Etoro.com Show details

On eToro, you can buy $ARCT or other stocks and pay ZERO commission! Follow Arcturus Therapeutics Holdings Inc share price and get more information. Terms apply.

Category: Contact NumberShow more

Arcturus Therapeutics Reports Inducement Grant Under

2 hours ago Finance.yahoo.com Show details

SAN DIEGO, October 21, 2021--Arcturus Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Category: Contact NumberShow more

Arcturus Therapeutics Issues Open Letter to Shareholders

8 hours ago Bloomberg.com Show details

018-03-28Arcturus Therapeutics Issues Open Letter to Shareholders Details Former President and CEO Joseph E. Payne’s Poor Judgment, Failed Leadership and Deceit that Led to His Termination for Cause

Category: Contact NumberShow more

Is Arcturus Therapeutics Holdings Inc (ARCT) a Winner in

Just Now Investorsobserver.com Show details

Arcturus Therapeutics Holdings Inc ( ARCT) is near the top in its sector according to InvestorsObserver . ARCT gets an overall rating of 37. That means it scores higher than 37% of stocks. Arcturus Therapeutics Holdings Inc gets a 83 rank in the Healthcare sector. Healthcare is number 6 out of 11 sectors.

Category: Contact NumberShow more

Arcturus Therapeutics Reports Inducement Grant Under

2 hours ago Finance.yahoo.com Show details

SAN DIEGO, November 19, 2021--Arcturus Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Category: Contact NumberShow more

Where Will Arcturus Therapeutics Holdings Inc (ARCT) Stock

4 hours ago Investorsobserver.com Show details

Arcturus Therapeutics Holdings Inc (ARCT) stock is higher by 17.88% while the S&P 500 has fallen -0.51% as of 12:54 PM on Thursday, Dec 16. ARCT is up $6.35 from the previous closing price of $35.52 on volume of 1,347,248 shares. Over the past year the S&P 500 has gained 26.83% while ARCT has fallen -61.74%.

Category: Contact NumberShow more

S3

1 hours ago Sec.gov Show details

(858) 900-2660Following the redomiciliation, the Company became the successor issuer to Arcturus Ltd. and each of Arcturus Ltd. and Arcturus Inc. became wholly-owned subsidiaries of the Company. Our principal executive offices are located at 10628 Science Center Drive, Suite 250, San Diego, California 92121, and our telephone number is (858) 900-2660.

Category: Contact NumberShow more

ARCT Is Its Stock Price A Worthy Investment? Learn More.

3 hours ago Stocknews.com Show details

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT)s share price gapped up before the market opened on Thursday . The stock had previously closed at $42.65, but opened at $43.86. Arcturus Therapeutics shares last traded at $42.00, with a volume of 2,855 shares. ARCT has been the subject of a number of analyst reports.

Category: Contact NumberShow more

Arc Therapeutics Innovative Oncology Therapeutics

9 hours ago Arc-therapeutics.com Show details

About ARC Therapeutics As cyclin-dependent kinases (CDKs) are key regulators of critical biological processes supporting cellular proliferation and growth, there are a number of novel cancer targets worthy of drug development pursuit within this family.

Category: Contact NumberShow more

Arcturus Stock Price ARCT 39.87 0.77 (1.9692999999999998%)

8 hours ago Macroaxis.com Show details

Arcturus Therapeutics is selling for under 39.87 as of the 29th of December 2021; that is 1.97 percent increase since the beginning of the trading day. The stock's last reported lowest price was 39.87. Get the latest Arcturus Therapeutics detailed stock quotes, stock trade data, stock price info, and performance analysis, including Arcturus Stock investment advice, charts, stats and …

Category: Contact NumberShow more

Arcturus Therapeutics receives $220M from Singapore for

4 hours ago Biospectrumasia.com Show details

Arcturus Therapeutics Holdings Inc., based in the US, has announced positive interim clinical study results from its ongoing Phase 1/2 study of ARCT-021, its vaccine candidate for COVID-19. The Company also announced new manufacturing financial support and potential vaccine purchases up to $220 million from Singapore’s Economic Development

Category: Contact NumberShow more

Novartis Oncology Patient Support and Financial Assistance

1 hours ago Patient.novartisoncology.com Show details

Novartis Oncology Patient Support is designed to help meet the needs of patients and caregivers by making it easier to access Novartis Oncology medicine (s). Patient Assistance Now Oncology (PANO) representatives will guide you to patient support options that fit your needs. If you are looking for financial assistance, support programs, and/or

Category: Support NumberShow more

ARCT Stock Snapshot Fidelity

2 hours ago Eresearch.fidelity.com Show details

Arcturus Therapeutics Holdings Inc (ARCT) : * ARCTURUS THERAPEUTICS REPORTS NEW DATA AND PROVIDES ADDITIONAL UPDATES FROM ARCT-154 AND ARCT-165 CLINICAL TRIALS. * Arcturus Therapeutics Holdings Inc (ARCT) - TO EVALUATE SERA FROM ARCT-154 AND ARCT-165 VACCINATED PARTICIPANTS FOR ACTIVITY …

Category: Contact NumberShow more

Arcturus Therapeutics Stock Analysis 2022 ARCT Macroaxis

7 hours ago Macroaxis.com Show details

858 900 2660Arcturus Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 118 people. For more info on Arcturus Therapeutics please contact Tord Cederlund at 858 900 2660 or go to https://www.arcturusrx.com. Arcturus Therapeutics Investment Alerts

Category: Contact NumberShow more

Starr Trademark Arcturus Therapeutics, Inc. San Diego, CA

6 hours ago Bizapedia.com Show details

10628 Science Center Drive, Suite 250. San Diego, CA 92121. Case File Statements. CODE. DESCRIPTION. GS0051. Biological Compound For Medical Use, Namely, Enhanced Ribonucleic Acid Delivered Into Patient Cells; Biological Compounds Being A Component In Vaccines; Therapeutic Agents For Generating Protective Immune Response; Molecularly Engineered

Category: Contact NumberShow more

Statement of Ownership (sc 13g) ADVFN

7 hours ago Ih.advfn.com Show details

OMB Number: 3235-0145. Estimated average burden hours per response ….11 . UNITED STATES. SECURITIES AND EXCHANGE COMMISSION. Washington, D.C. 20549. SCHEDULE 13G. Under the Securities Exchange Act of 1934 (Amendment No. _____*) ARCTURUS THERAPEUTICS HOLDINGS, INC. (Name of Issuer) COMMON STOCK (Title of …

Category: Contact NumberShow more

A Trial Evaluating the Safety and Immunogenicity of 3

7 hours ago Clinicaltrials.gov Show details

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor. Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05037097

Category: Contact NumberShow more

Arcturus Therapeutics (ARCT) Expected to Beat Earnings

8 hours ago News.yahoo.com Show details

So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number. For the last reported quarter, it was expected that Arcturus Therapeutics would post a loss of $0.24 per share when it actually produced a loss of $0.56, delivering a surprise of -133.33%.

Category: Contact NumberShow more

Pandemics/Epidemics (Free) Patent Forecast Magic Number

2 hours ago Patentforecast.magicnumberip.com Show details

020-06-11A less-known yet still promising player, Arcturus Therapeutics, who was acquired by Ultragenyx Pharmaceutical recently, also announced on May 8 their positive preclinical data with their LUNAR-COV19 vaccine, Contact Us. Magic Number 7806 Hwy 751, Suite 130 Durham, NC 27713.

Category: Contact NumberShow more

ARCTURUS THERAPEUTICS HOLDINGS INC. : ARCT Stock Price

8 hours ago Marketscreener.com Show details

Arcturus Therapeutics Holdings Inc. is a clinical-stage messenger ribonucleic acid (mRNA) medicines company. The Company is engaged in the development of infectious disease vaccines, and significant opportunities within liver and respiratory rare diseases.

Category: Contact NumberShow more

ARCT154 Wikipedia

8 hours ago En.wikipedia.org Show details

ARCT-154, also known as VBC-COV19-154 in Vietnam, is a COVID-19 vaccine candidate developed by Arcturus Therapeutics. [1] [2] For its development, Arcturus collaborated with Vinbiocare , a Vietnamese company, for support with clinical trials and manufacturing.

Category: Contact NumberShow more

All Time Past 24 Hours Past Week Past month

Please leave your comments here:

Brand New Updated

Frequently Asked Questions

Who is Arcturus Therapeutics?

With its unique mRNA therapeutics platform, Arcturus Therapeutics is a leading clinical-stage mRNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases.

Is Arcturus Therapeutics Holdings Inc (ARCT) stock too volatile?

In terms of volatility of its share price, ARCT is more volatile than 96.43% of stocks we're observing. Stocks with similar financial metrics, market capitalization, and price volatility to Arcturus Therapeutics Holdings Inc are XENE, PTGX, SGMO, TTNP, and ENTA.

What's new at Arcturus?

Arcturus is combining its self-replicating mRNA STARR technology with LUNAR to develop a prophylactic vaccine against influenza. LUNAR-GSD is a project in collaboration with Ultragenyx to treat glycogen storage disease type III.

Why choose arc Therapeutics?

The founding members of the ARC Therapeutics team have unparalleled expertise in developing selective CDK inhibitors and a proven track record of successfully developing novel therapeutics to advance patient care. © 2021 Arc Therapeutics, Inc.

Popular Brands

Amazon
Abbvie
Asml
Aia
Att
Apple
Amgen
Adobe
Aptar
Acc
Adidas
Aak